UNSPSC 51111663: Valopicitabine

This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I2T0B5G94M. European Medicines Agency schedules Valopicitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35614. Valopicitabine generally arises in the molecular formula C15H24N4O6.

UNSPSC 51111663 Valopicitabine is a Commodity code that, based on recent state procurement activity, captures pharmaceutical products sourced through state health and human services agencies as part of broader pharmacy benefit and direct-to-manufacturer procurement initiatives. The Texas Health and Human Services Commission issued a Request for Information in April 2026 to gather market intelligence on establishing direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers, signaling state interest in alternative supply channels and cost-management strategies that circumvent traditional pharmacy benefit managers and group purchasing organizations. State health and human services departments appear to be the primary issuing bodies under this code, with procurement focused on consolidating pharmaceutical sourcing and optimizing fulfillment efficiency across state employee and retiree health plans.

The recent activity is concentrated in Texas, where the Health and Human Services Commission's RFI represents the most current solicitation on file. The April 2026 RFI sought vendor responses regarding direct-contracting capabilities, negotiated net pricing models, and value-based agreement implementation, though no formal evaluation criteria, award amounts, or binding timelines were established in that preliminary information-gathering phase. This RFI signals that Texas intends to follow with a formal Request for Proposal once vendor capabilities are assessed, but no subsequent RFP has been posted as of the current date. Activity under this code remains limited to this single jurisdiction and exploratory procurement stage.